HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Daniel E Singer Selected Research

Warfarin (Coumadin)

2/2015Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial.
1/2015Alternative Calculations of Individual Patient Time in Therapeutic Range While Taking Warfarin: Results From the ROCKET AF Trial.
1/2015Comparison of Frequency and Outcome of Major Gastrointestinal Hemorrhage in Patients With Atrial Fibrillation on Versus Not Receiving Warfarin Therapy (from the ATRIA and ATRIA-CVRN Cohorts).
12/2014Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial.
10/2014Reasons for warfarin discontinuation in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).
8/2014Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.
7/2014Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial.
7/2014Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).
6/2014Use and outcomes of antiarrhythmic therapy in patients with atrial fibrillation receiving oral anticoagulation: results from the ROCKET AF trial.
6/2014Rivaroxaban for stroke prevention in East Asian patients from the ROCKET AF trial.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $490.00 USD

Daniel E Singer Research Topics

Disease

51Stroke (Strokes)
02/2015 - 11/2002
47Atrial Fibrillation
02/2015 - 11/2002
32Hemorrhage
02/2015 - 11/2002
25Embolism (Embolus)
02/2015 - 11/2003
12Intracranial Hemorrhages (Intracranial Hemorrhage)
01/2015 - 11/2003
11Heart Failure
02/2015 - 09/2004
8Hypertension (High Blood Pressure)
01/2014 - 06/2002
8Thromboembolism
11/2010 - 11/2003
6Transient Ischemic Attack
05/2014 - 09/2004
5Diabetes Mellitus
02/2012 - 08/2002
4Pneumonia (Pneumonitis)
09/2002 - 02/2002
3Myocardial Infarction
06/2014 - 12/2006
3Thrombosis (Thrombus)
06/2008 - 03/2003
2Cardiovascular Diseases (Cardiovascular Disease)
12/2006 - 06/2002
2Cerebral Hemorrhage
04/2004 - 07/2003
1Gastrointestinal Hemorrhage (Hematochezia)
01/2015
1Mitral Valve Stenosis (Mitral Stenosis)
12/2014
1Hypersensitivity (Allergy)
04/2014
1Anemia
03/2014
1Chronic Obstructive Pulmonary Disease (COPD)
03/2014
1Peripheral Arterial Disease
01/2014
1Intermittent Claudication
01/2014
1Abdominal Aortic Aneurysm
01/2014
1Tachycardia (Tachyarrhythmias)
10/2009
1Unstable Angina
12/2006
1Respiratory Tract Infections (Respiratory Tract Infection)
10/2003
1Sinusitis
05/2003
1Diabetes Complications
08/2002
1Hypercholesterolemia
06/2002
1Liver Diseases (Liver Disease)
05/2002
1Leukopenia
05/2002
1Hypothermia
05/2002
1Anoxia (Hypoxia)
05/2002
1Intravenous Substance Abuse
02/2002
1Dementia (Dementias)
02/2002
1Neoplasms (Cancer)
02/2002

Drug/Important Bio-Agent (IBA)

50Warfarin (Coumadin)FDA LinkGeneric
02/2015 - 03/2003
22rivaroxabanIBA
02/2015 - 09/2011
20Vitamin KFDA Link
02/2015 - 11/2002
18Factor Xa (Coagulation Factor Xa)IBA
02/2015 - 09/2005
15Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
03/2014 - 11/2002
8AnticoagulantsIBA
12/2014 - 11/2002
4CreatinineIBA
07/2014 - 01/2013
2Digoxin (Digitek)FDA LinkGeneric
02/2015 - 01/2004
2clopidogrel (Plavix)FDA Link
02/2012 - 09/2005
2Fibrinolytic Agents (Antithrombotic Agents)IBA
09/2005 - 02/2004
2Anti-Bacterial Agents (Antibiotics)IBA
10/2003 - 05/2003
2NitrogenIBA
05/2002 - 02/2002
2Urea (Carbamide)FDA LinkGeneric
05/2002 - 02/2002
1N(4)-oleylcytosine arabinosideIBA
09/2014
1Serotonin Uptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
08/2014
1Antidepressive Agents (Antidepressants)IBA
08/2014
1Serotonin (5 Hydroxytryptamine)IBA
08/2014
1Anti-Arrhythmia AgentsIBA
06/2014
1Amiodarone (Amiodarona)FDA LinkGeneric
06/2014
1Serum AlbuminIBA
05/2014
1EOSIBA
07/2013
1triflusalIBA
04/2009
1Bupropion (Wellbutrin)FDA LinkGeneric
12/2006
1ximelagatran (Exanta)IBA
09/2005
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
09/2005
1ThrombinFDA Link
09/2005
1CholesterolIBA
05/2004
1Calcium Channel Blockers (Blockers, Calcium Channel)IBA
01/2004
1Calcium Channels (Calcium Channel)IBA
01/2004
1Heparin (Liquaemin)FDA LinkGeneric
03/2003
1factor V LeidenIBA
02/2003
1Glucose (Dextrose)FDA LinkGeneric
08/2002
1Hemoglobins (Hemoglobin)IBA
08/2002

Therapy/Procedure

3Electric Countershock (Cardioversion)
05/2013 - 09/2004
3Length of Stay
12/2006 - 02/2002
2Defibrillators (Defibrillator)
02/2010 - 10/2009
1Prostheses and Implants (Prosthesis)
12/2014
1Amputation
01/2014
1Thrombolytic Therapy
09/2004
1Intensive Care (Surgical Intensive Care)
09/2002
1Artificial Respiration (Mechanical Ventilation)
09/2002
1Drug Therapy (Chemotherapy)
06/2002
1Resuscitation Orders (Do Not Resuscitate Orders)
02/2002
1Home Nursing (Nursing, Home)
02/2002